Thus, the results of our complementary in vitro and in silico stability assays suggest that cancer-associated PBRM1-BD4 missense variants with affected residues in either the Kac binding loops or the structural core are sufficient to destabilize PBRM1-BD4 due to disruption of crucial bromodomain functional regions. The gene discussed is PBRM1; the disease is cancer.